Warehouse Fall Case Study: Back Injury, Workers' Comp Gap, and Pharmacy Lien

James Wong — Founder & Pharmacist, LienScripts | February 10, 2026 | 9 min read

A warehouse worker falls from a defective rolling ladder supplied by a third-party vendor, sustaining an L3-L4 disc herniation. Workers' comp denied gabapentin and topical diclofenac. A pharmacy lien covered the gap for 14 months — and the MERIT helped establish damages against the equipment manufacturer.

Case Background

Note: This is a fictionalized case study based on composite facts. Names and identifying details are not real. The clinical details represent typical medication patterns for this injury type.

The Client: Marcus T., 36, a lead warehouse associate at a large regional distribution center in Riverside County, California.

The Incident: Marcus was using a rolling A-frame ladder — a piece of equipment supplied by a third-party materials handling vendor under a lease agreement with his employer — to retrieve inventory from a high shelf. The ladder's locking mechanism failed without warning, causing the rungs to collapse. Marcus fell approximately eight feet, landing directly on his lower back and left side on a concrete warehouse floor.

The Legal Structure:

Marcus filed a workers' compensation claim immediately through his employer. Because the ladder failure was caused by a defective product supplied by a vendor — not by any act or omission of his employer — his personal injury attorney also identified a viable third-party product liability claim against the equipment manufacturer and the lease vendor. California allows injured workers to pursue third-party tort claims alongside workers' comp when the injury was caused by a party other than the employer. (See California Labor Code § 3852.)

LienScripts was enrolled after Marcus's PI attorney recognized that several prescribed medications were being denied by the workers' comp carrier's pharmacy benefit manager, creating treatment gaps that would affect both Marcus's recovery and the strength of his damages narrative.

[!KEY] California workers' compensation pharmacy benefits are governed by a closed formulary (MTUS/ACOEM guidelines). Medications outside that formulary — including many neuropathic pain agents and topical analgesics — require physician preauthorization that is frequently denied. When a third-party PI claim runs parallel to workers' comp, a pharmacy lien covers exactly these denied medications and documents them independently of the workers' comp record.

Injuries Sustained

Imaging obtained in the first two weeks confirmed:

• L3-L4 disc herniation with left-sided foraminal encroachment
• Left lower extremity radiculopathy — radiating pain, numbness, and intermittent foot drop symptoms
• Lumbar paraspinal muscle strain with spasm
• Left elbow contusion and soft tissue bruising (fall impact, non-surgical)

The radiculopathy was the most clinically significant finding. Marcus described constant burning pain from his left hip through his thigh and calf, with numbness in his foot that made standing for extended periods impossible. His treating orthopedic spine specialist and pain management physician both emphasized that neuropathic pain management was a central component of his recovery plan.

Workers' Comp Pharmacy Coverage — and What It Denied

California's workers' comp formulary (based on MTUS guidelines) covered the following for Marcus:

• Cyclobenzaprine 10 mg — approved for muscle spasm
• Naproxen 500 mg — approved for inflammatory pain
• Short-course tramadol — approved post-injury for acute pain management

Workers' comp denied the following after preauthorization requests:

• Gabapentin 900 mg TID (2700 mg/day total) — prescribed by Marcus's pain management physician for left-sided radiculopathy. Workers' comp denied this as non-formulary without a second-line treatment failure demonstration. The denial letter cited MTUS guidelines restricting gabapentin's use within the first 90 days of injury.
• Diclofenac sodium topical gel 1% (Voltaren Rx strength) — prescribed to avoid systemic NSAID burden given Marcus's GI sensitivity to oral naproxen. Workers' comp denied this as a brand formulation substitutable by oral naproxen, ignoring the prescribing rationale.
• Omeprazole 20 mg — prescribed as GI protection given the extended NSAID course and Marcus's history of gastric sensitivity. Denied as not directly injury-related.

All three denied medications were enrolled in LienScripts from month one.

Medications on Pharmacy Lien

At month 3, Marcus's treating physician transitioned him from cyclobenzaprine (which was producing daytime sedation incompatible with physical therapy) to methocarbamol. Workers' comp approved the switch — but methocarbamol at therapeutic doses was only partially covered, with LienScripts covering the dosage gap.

At month 6, a lidocaine 5% patch was added for focal radicular pain relief during physical therapy sessions. Workers' comp denied this outright. LienScripts covered it through settlement.

[!KEY] The workers' comp formulary denial of gabapentin for documented radiculopathy is one of the most common coverage gaps in California warehouse and industrial injury cases. Gabapentin is clinically standard for neuropathic pain of this type — but because MTUS guidelines restrict its early use, patients are left without adequate neuropathic pain management unless a pharmacy lien fills the gap.

Treatment Timeline

Months 1–3 (Acute Phase): Marcus began physical therapy three times per week, treating with his orthopedic spine physician monthly and his pain management physician biweekly. Gabapentin was titrated from 300 mg to 900 mg three times daily over the first six weeks. The topical diclofenac was applied twice daily over the lumbar region as directed. Marcus showed measurable improvement in radicular symptoms at week eight but continued to have significant functional limitations.

Months 4–8 (Subacute/Rehabilitation Phase): Physical therapy continued twice weekly. Gabapentin held at 2700 mg/day with adequate but incomplete radicular relief. Methocarbamol replaced cyclobenzaprine at month 3 with better functional outcomes — Marcus reported less daytime sedation and improved participation in PT exercises. His treating physician ordered a follow-up MRI at month 6, which confirmed persistent disc herniation at L3-L4 without worsening. The lidocaine patch was added to provide focal analgesia during therapy sessions.

Months 9–12 (Workers' Comp MMI): At month 9, the workers' comp carrier's utilization review physician declared maximum medical improvement and terminated pharmacy benefits. Marcus's PI case was still active. All five medications continued under the pharmacy lien exclusively through settlement. Workers' comp continued to manage the primary medical care (physician visits, PT) through their IME and QME process, but pharmacy was now entirely on the lien.

Months 13–14 (Pre-Settlement): PI discovery closed. The product liability demand against the equipment manufacturer was finalized. The MERIT from LienScripts provided the attorney with a complete 14-month medication log — medication names, fill dates, days supplied, and prescribing physician — organized chronologically. The document supported both the damages narrative and Marcus's treating physicians' causation opinions.

The Product Liability Claim

Marcus's PI attorney pursued a product liability theory against both the ladder manufacturer and the lease vendor. Key elements of the claim:

Defective Design / Manufacturing Defect: Engineering inspection of the failed ladder revealed that the locking collar on the A-frame hinge had failed due to a casting defect in the aluminum housing — a manufacturing defect present at production.

Negligent Maintenance / Inspection: The vendor's maintenance records showed the ladder had not received its required annual inspection for 26 months prior to the incident.

Damages Documented:

• Lost wages during 14-month treatment arc
• Medical expenses: physician visits, imaging, physical therapy, and the pharmacy lien
• Non-economic damages: pain, loss of physical function, impact on work capacity
• Future treatment exposure: Marcus's spine specialist opined a likely surgical consultation at year two if conservative treatment failed

The MERIT role: The Medication Evaluation & Rationale for Injury Treatment provided a timeline-anchored medication record that corroborated the treating physicians' clinical notes. It established that Marcus's neuropathic pain management was continuous, escalating appropriately, and clinically managed — not abandoned or inconsistent. Defense attempts to argue over-treatment or non-compliance were directly rebutted by the fill record.

[!KEY] In product liability cases, the pharmacy lien record serves a dual function: it is both a component of economic damages (the lien balance is a real medical debt created by the defendant's negligence) and a clinical corroboration tool that supports causation and treatment necessity opinions from the treating physicians.

Settlement and Lien Resolution

Marcus's case settled with the equipment manufacturer and the lease vendor through their combined liability carriers at the end of month 14. The settlement addressed:

• Workers' comp subrogation (California Labor Code § 3856) — the workers' comp carrier had paid medical and wage benefits and held a subrogation interest, which was negotiated as part of the structured settlement process
• The pharmacy lien balance with LienScripts — resolved at settlement from the PI proceeds
• Attorney's fees and costs

Marcus received net proceeds after all liens and fees. His workers' comp case resolved concurrently through a compromise and release.

Key Takeaways

1. Third-party liability claims run parallel to workers' comp in California. When a defective product or negligent vendor caused the injury — not the employer — the injured worker has full access to both workers' comp benefits and a separate PI/product liability claim. A pharmacy lien covers medications that workers' comp denies.

2. Workers' comp formulary gaps are predictable in California. Gabapentin, topical analgesics, and GI protection agents are among the most commonly denied medications in industrial back injury cases. Attorneys who know these patterns can refer clients to LienScripts before the first denial letter arrives.

3. MERIT documentation is critical in product liability cases. A 14-month continuous pharmacy record showing appropriate escalation, treatment compliance, and prescriber management is a powerful exhibit in the damages phase of a product liability case.

4. Workers' comp MMI does not end the patient's medication needs. When workers' comp cuts off pharmacy benefits at MMI, the PI case is often still months from settlement. The pharmacy lien bridges that gap without interrupting the patient's clinical care.

Related Resources

• Construction Accident Injury and Pharmacy Lien
• Case Study: Workers' Comp Dual Claim
• Herniated Disc Medications and Pharmacy Lien
• Gabapentin vs. Pregabalin for Personal Injury Patients
• What Is a MERIT Report?